Detects mutations within exon 12 of the NPM1 gene associated with acute myeloid leukaemia.
Used to support the classification and prognostic assessment of acute myeloid leukaemia. When an NPM1 mutation is identified at diagnosis, an appropriately validated quantitative test may subsequently be used for disease monitoring.